Newsroom
Newsroom
Industry News
Antheia reconstructs complex biochemical pathways in yeasts to speed up production of natural product-based drugs......
Industry News
California synthetic biology firm Antheia has joined forces with Boston-based biotech company Ginkgo Bioworks to strengthen its efforts to develop and produce essential medicines to...
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a...
Industry News
With supply chain shortages at the forefront of nearly every business in the world right now, whether it be chicken wings or CAR-T cell therapy,...
Industry News
Fundraising at Bota Bio, Genomatica, and Antheia signals an upshift for commercial-scale synthetic biology......
Industry News
Antheia, a Menlo Park CA-based synthetic biology company, raised $73M in Series B funding. The round was led by Viking Global Investors with participation from...